Interestingly, the percentage of INF/immune high versus IE/immune low using Sema4D scoring in the current cohort (Figure 2) is in concordance with the previously reported immunoscore using CD3/CD8 in HNSCC (7, 40, 41). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.